Genexine Inc.

The hopes of spring may be returning to the South Korean biotech industry after a series of encouraging developments in recent months has more than made up for some other disappointing news, with prog

Amid prolonged difficulties in the financing environment this year, South Korean biotech firms including Genexine Inc. and Bridge Biotherapeutics, Inc. have opted to suspend low-priority R&D proje

Genexine Inc. , established more than 20 years ago, has now reached a juncture where it needs significant changes in strategy to move forward towards its ambition of become a leading global biopharma

Tiba, CEPI Strive To Plan Ahead For Next Pandemic Tiba Biotech LLC and CEPI (Coalition for Epidemic Preparedness Innovations) said on 12 January that they will partner to evaluate the Cambridge, M